Cargando…

Foretinib Enhances the Radiosensitivity in Esophageal Squamous Cell Carcinoma by Inhibiting Phosphorylation of c-Met

As a crucial event involved in the metastasis and relapse of esophageal cancer, c-Met overexpression has been considered as one of the culprits responsible for the failure in patients who received radiochemotherapy. Since c-Met has been confirmed to be pivotal for cell survival, proliferation and mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Guang-Zong, Dai, Wang-Shu, Zhu, Hong-Cheng, Song, Hong-Mei, Yang, Xi, Wang, Yuan-Dong, Min, Hua, Lu, Qian, Liu, Shu, Sun, Xin-Chen, Zeng, Xiao-Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436250/ https://www.ncbi.nlm.nih.gov/pubmed/28529610 http://dx.doi.org/10.7150/jca.18135

Ejemplares similares

Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma
por: Hassan, Md. Sazzad, et al.
Publicado: (2019)

Foretinib Inhibits Cancer Stemness and Gastric Cancer Cell Proliferation by Decreasing CD44 and c-MET Signaling
por: Sohn, Sung-Hwa, et al.
Publicado: (2020)

56. Foretinib Enhances Myelination of Neurons in Vitro
por: Mirmoeini, Kaveh, et al.
Publicado: (2023)

Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
por: Simiczyjew, Aleksandra, et al.
Publicado: (2018)

Upregulation of microRNA-98 increases radiosensitivity in esophageal squamous cell carcinoma
por: Jin, Ying-Ying, et al.
Publicado: (2016)

Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
por: Fu, Yuyin, et al.
Publicado: (2021)

Targeted dual inhibition of c‐Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models
por: Grojean, Meghan, et al.
Publicado: (2021)

Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation
por: Fujino, Toshio, et al.
Publicado: (2022)

Radiosensitizing effect of c-Met kinase inhibitor BPI-9016M in esophageal squamous cell carcinoma cells in vitro and in vivo
por: Jiang, Chenxue, et al.
Publicado: (2021)

NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc
por: Wang, Yuwen, et al.
Publicado: (2018)

lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET
por: Wang, Pan, et al.
Publicado: (2020)

Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling
por: Chen, Hsiu-Mei, et al.
Publicado: (2015)

Foretinib mitigates cutaneous nerve fiber loss in experimental diabetic neuropathy
por: Daeschler, Simeon C., et al.
Publicado: (2022)

Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling
por: Ji, Xiwei, et al.
Publicado: (2023)

Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells
por: Fu, Shenbo, et al.
Publicado: (2018)

Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3
por: Zhao, Lei, et al.
Publicado: (2012)

Phase II trial of single-agent foretinib (GSK1363089) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
por: Seiwert, Tanguy, et al.
Publicado: (2012)

Foretinib (GSK1363089) induces p53-dependent apoptosis in endometrial cancer
por: Kogata, Yuhei, et al.
Publicado: (2018)

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas
por: Lüttich, Lina, et al.
Publicado: (2021)

Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma
por: An, Lingbo, et al.
Publicado: (2023)

Relationship between TLR4 and NF-κB p65 protein expressions and clinical radiosensitivity of patients with esophageal squamous cell carcinoma
por: Tang, Hua, et al.
Publicado: (2014)

Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
por: Shah, Manish A., et al.
Publicado: (2021)

Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
por: Shah, Manish A., et al.
Publicado: (2022)

Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines
por: Dratkiewicz, Ewelina, et al.
Publicado: (2018)

Silencing UBQLN2 Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma (ESCC) via Activating p38 MAPK
por: Wang, Jia-Lin, et al.
Publicado: (2023)

Experimental study on the regulation of erlotinib-induced radiosensitization with an anti-c-MET monoclonal antibody
por: Zhuang, Hong-Qing, et al.
Publicado: (2014)

MET overexpression and intratumor heterogeneity in esophageal squamous cell carcinoma
por: Abboud, H.S., et al.
Publicado: (2021)

Correction: Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
Publicado: (2022)

High expression of CIN85 promotes proliferation and invasion of human esophageal squamous cell carcinoma
por: Hua, Xiao-Yang, et al.
Publicado: (2021)

Ultrasound-Stimulated Microbubbles Inhibit Aggressive Phenotypes and Promotes Radiosensitivity of esophageal squamous cell carcinoma
por: Shi, Jinjun, et al.
Publicado: (2021)

The prognostic effect of perineural invasion in esophageal squamous cell carcinoma
por: Chen, Jie-Wei, et al.
Publicado: (2014)

MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer
por: Ramesh, Shrey, et al.
Publicado: (2023)

Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients
por: Wang, Yanqiu, et al.
Publicado: (2019)

Baicalein Inhibits the Progression and Promotes Radiosensitivity of Esophageal Squamous Cell Carcinoma by Targeting HIF-1A
por: Guo, Dongli, et al.
Publicado: (2022)

Plumbagin Enhances the Radiosensitivity of Tongue Squamous Cell Carcinoma Cells via Downregulating ATM
por: Pan, Shu-Ting, et al.
Publicado: (2021)

Diisopropylamine dichloroacetate enhances radiosensitization in esophageal squamous cell carcinoma by increasing mitochondria-derived reactive oxygen species levels
por: Dong, Gaochao, et al.
Publicado: (2016)

MicroRNA-27a downregulates the expression of Hsp90 and enhances the radiosensitivity in esophageal squamous cell carcinoma
por: Wang, Xintong, et al.
Publicado: (2019)

Inhibitory Role of Pentraxin-3 in Esophageal Squamous Cell Carcinoma
por: Ma, Dan, et al.
Publicado: (2016)

Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma
por: Luo, Li-Ling, et al.
Publicado: (2015)

Down-regulation of XIAP enhances the radiosensitivity of esophageal cancer cells in vivo and in vitro
por: Wen, Xin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ldje9ggf9g9amfasf654p4f5a4